Indiana Medicaid (IHCP)Medicaid · Prior Auth · Claims & Billing · IN · Endocrinology, Family Medicine, Internal MedicineMedium impact
BT2023114: IHCP summarizes billing guidelines for diabetes testing supplies
Act
immediately
Effective date
Jan 1, 2023
Identified
Jun 19, 2026
Summary
Indiana Health Coverage Programs (IHCP) clarified billing guidelines for diabetes testing supplies, eliminating prior authorization requirements for preferred CGM products effective January 1, 2023, while maintaining PA requirements for non-preferred products. Professional claims must include 11-digit NDC or UDI codes for all diabetes testing supplies.
Get alerts when payers change rules like this one
We check Indiana Medicaid (IHCP) and other payers every day and email you when a change matches your specialty and state.
01Billing team must verify that claims for diabetes testing supplies (CGM and SBGM) include required 11-digit National Drug Code (NDC) or unique device identifier (UDI) in billing system.
02Update claim submission processes to ensure preferred diabetes products from PDSL do not require prior authorization, while non-preferred products still need PA with medical necessity documentation.
03Pharmacy providers must submit all diabetes supply claims via point-of-sale (POS) system.
Codes mentioned
A4238A4239A4253E0607E2102E2103
Original notice
BT2023114: IHCP summarizes billing guidelines for diabetes testing supplies
in.gov · Always check the source before changing claims.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.